Research Studies and Clinical Trials Search
Results
Alagille Syndrome (ALGS): A study on the long-term safety and effectiveness of Livmarli
This study is being done for children: • With a Alagille Syndrome (AlGS) diagnosis • Currently taken Livmarli. The purpose of this research study is to evaluate the long-term safety and outcomes of patients with Alagille Syndrome...
This study is being done for children: • With a Alagille Syndrome (AlGS) diagnosis • Currently taken Livmarli. The purpose of this research study is to evaluate the long-term safety and outcomes of patients with Alagille Syndrome (ALGS) who are prescribed Livmarli (maralixibat).
Alagille Syndrome: A registry study of odevixibat in individuals with Alagille syndrome.
This study is enrolling participants who: - Have a diagnosis of Alagille syndrome - Currently taking odevixibat...
This study is enrolling participants who: - Have a diagnosis of Alagille syndrome - Currently taking odevixibat Alagille syndrome is a rare disease that can cause problems in the liver. The purpose of this study is to collect long-term data to see if odevixibat is safe and effective.
Hepatitis B Infection: A clinical study of tenofovir alafenamide in children and adolescents with long term hepatitis B infection
This study is enrolling participants who: - Are children who are 2 to less than 6 years of age - Have chronic (long term) hepatitis B virus infection...
This study is enrolling participants who: - Are children who are 2 to less than 6 years of age - Have chronic (long term) hepatitis B virus infection Chronic Hepatitis B is a viral liver infection. The purpose of this study is to see if Tenofovir Alafenamide is safe, tolerable, and effective in treating children and adolescents with hepatitis B virus infection.